Evidence map›Paper›PMID 35393750›Full record

ReviewNephrology (Carlton, Vic.)2022

Peritoneal dialysis first policy in Hong Kong for 35 years: Global impact.

Philip Kam-Tao Li, Wanhong Lu, Siu-Ka Mak, Neil Boudville, Xueqing Yu, Ming Ju Wu, Yuk-Lun Cheng, Christopher T Chan, Bak Leong Goh, Na Tian and 3 more

Abstract readReview
In one paragraph

Review in Nephrology (Carlton, Vic.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Unveiling Challenges Hindering the Growth of Home Dialysis in Finland: Insights From 40 Years of Experience.Hemodialysis international. International Symposium on Home Hemodialysis · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. The future of peritoneal dialysis.Clinical kidney journal · 2024
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Philip Kam-Tao LiDepartment of Medicine and Therapeutics, Carol and Richard Yu Peritoneal Dialysis Research Centre, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, SAR, China.ORCID https://orcid.org/0000-0001-9879-8388
Wanhong LuDepartment of Nephrology, Kidney Hospital, The First Affiliated Hospital of Xi'an, Jiaotong University, Xi'an, China.
Siu-Ka MakDepartment of Medicine and Geriatrics, Kwong Wah Hospital, Hong Kong, SAR, China.
Neil BoudvilleDepartment of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.ORCID https://orcid.org/0000-0002-5884-640X
Xueqing YuDepartment of Nephrology, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China.ORCID https://orcid.org/0000-0001-8624-744X
Ming Ju WuDivision of Nephrology, Department of Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Yuk-Lun ChengDepartment of Medicine, Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong.
Christopher T ChanDivision of Nephrology, University Health Network, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-0947-7273
Bak Leong GohDepartment of Nephrology, Hospital Serdang, Kajang, Selangor, Malaysia.ORCID https://orcid.org/0000-0002-4644-7743
Na TianDepartment of Nephrology, General Hospital of Ningxia Medical University, Ningxia, China.ORCID https://orcid.org/0000-0002-0284-5897
Kai Ming ChowDepartment of Medicine and Therapeutics, Carol and Richard Yu Peritoneal Dialysis Research Centre, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, SAR, China.ORCID https://orcid.org/0000-0001-5310-5197
Sing Leung LuiDepartment of Medicine, Tung Wah Hospital, Hong Kong.
Wai Kei LoDialysis Centre, Gleneagles Hospital, Hong Kong, SAR, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peritoneal dialysis (PD) first policy has been established in Hong Kong since 1985. After 35 years of practice, the PD first policy in Hong Kong has influenced many countries around the world including governments, health ministries, nephrologists and renal nurses on the overall health policy structure and clinical practice in treating kidney failure patients using PD as an important dialysis modality. In 2021, the International Association of Chinese Nephrologists and the Hong Kong Society of Nephrology jointly held a symposium celebrating the 35 years of PD first policy in Hong Kong. In that symposium, experts and opinion leaders from around the world have shared their perspectives on how the PD first policy has grown and how it has affected PD and home dialysis practice globally. The advantages of PD during COVID-19 pandemic were highlighted and the use of telemedicine as an important adjunct was discussed in treating kidney failure patients to improve the overall quality of care. Barriers to PD and the need for sustainability of PD first policy were also emphasized. Overall, the knowledge awareness of PD as a home dialysis for patients, families, care providers and learners is a prerequisite for the success of PD first. A critical mass of PD regional hubs is needed for training and mentorship. Importantly, the alignment of policy and clinical goals are enablers of PD first program.

Indexed as

COVID-19Kidney Failure, ChronicPeritoneal DialysisHealth PolicyHong KongHumansPandemicsRenal Dialysisglobal impactHong KongPD first policyperitoneal dialysis

Identifiers

PMID35393750
PMCPMC9790333

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.